Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the trimaster study

HIGHLIGHTS

• who: Beverley M. Shields from the (UNIVERSITY) have published the article: Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study, in the Journal: (JOURNAL) of 22/Nov/2016
• what: The authors show here that, among patients with type 2 diabetes on background metformin or combination metformin and sulfonylurea therapy, stratification based on BMI and eGFR is associated with differential glucose-lowering responses to canagliflozin, sitagliptin and pioglitazone. The authors show here, in a randomized crossover study, that clinically relevant differences in glycemic responses to therapy in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.